diabetes header graphic


Avoiding Diabetes Complications
By Adrian Whittle
The numbers of people that have been diagnosed with in the past 20 years has increased to such an extent that many are describing the situation as an epidemic. This may be explained by people becoming more aware of the disease and thus diagnosing the condition more readily but the fact is that the disease is increasing at an unprecedented level. This increase is mainly in type 2 that is the result of insulin resistance. It is generally associated with older people and is often termed adult onset diabetes. Type 2 is generally the easier disease to manage and a person can lead a normal life, often without any form of medication, if they adhere to guidelines set by their doctor. It is important to follow the treatment guidelines given by your doctor or health care provider not just for your day to day life but for the long term complications that can result from diabetes. This article will cover the typical care regime for and the possible complications that can result if you do not follow these guidelines.

Treatment or care for type 2 comes down to four things. Eating the right food, getting proper and regular exercise, monitoring your blood sugar level and getting regular check ups. The sooner you adopt these potential changes in your lifestyle the less risk you may face of getting any diabetic complications.

When you are first diagnosed with diabetes, you will be educated on how the disease affects your body. Part of this education will be how to minimize this by eating the right foods. You will consult your doctor or a dietitian who will give you ideas on the types and quantities of food to eat. They will devise a meal plan

Could you have diabetic kidney disease and not even know it?
Questions to ask your doctor.

]]>

Diabetes is the leading cause of chronic kidney disease

Chronic kidney disease (CKD) is on the rise in part because diabetes is on the rise. If you are at risk for diabetes or have been recently diagnosed with the disease, here’s what you should know about the link between diabetes and CKD.

]]>

Diabetes and minorities: What are the risks?
Some ethnic groups develop diabetes at two to six times the rate of whites. If you are African American, Hispanic, Native American, Asian or Pacific Islander, here’s what you should know about your risk for diabetes.

]]>

Preventing chronic kidney disease when you have diabetes

Diabetes is the leading cause of chronic kidney disease. Keeping diabetes in check and early diagnosis of kidney disease could help decrease the chances of developing kidney failure.

]]>

Diet tips for diabetics with kidney disease
When diabetes leads to kidney disease the goal is to preserve kidney function as long as possible and manage diabetes. What you eat can affect both your blood sugar and your kidney function. A dietitian will work with you to create an eating plan that's right for you, probably using some of the diet tips presented here.

]]>

Introduction

Diabetes: definition, causes and symptoms

For a while now, a?leading topic in the United States has been?about the growing number of people?diagnosed with diabetes. But what exactly is diabetes? Here you'll find the definition, causes and signs of diabetes.

]]>

Controlling diabetes
Diabetes is the leading cause of chronic kidney disease in the United States. By controlling diabetes through lifestyle choices such as diet and exercise, taking prescribed medicines and seeing a doctor regularly, people with diabetes can usually maintain a healthy lifestyle and help prevent chronic kidney disease and kidney failure. Find out what you can do to control diabetes.

]]>

Diabetes and chronic kidney disease
Diabetes and chronic kidney disease

Diabetes is the leading cause of chronic kidney disease in America. Many people with diabetes are not aware that chronic kidney disease can lead to kidney failure. However, having diabetes does not necessarily mean you will have kidney failure. Learn about the diabetes and kidney disease connection and how you can keep your kidneys healthy.

]]>

Preventing diabetic kidney disease
All about diabetes Preventing diabetic kidney disease How can I slow the progression of kidney disease? Keeping healthy is the most important part of delaying kidney disease. If you have diabetes and have been diagnosed with an early stage of chronic kidney disease, following your doctor?s instructions regard

]]>

Get the facts

Are you in control of your diabetes?
If you have diabetes, your doctor advises you to keep your glucose levels in a healthy range. One of the problems that can occur for diabetics who don’t control their diabetes is the risk of kidney disease which may lead to kidney failure and dialysis. Diabetes is the leading cause of kidney disease in America. Learn how you can control your diabetes to avoid other health complications such as renal disease.

]]>

Diabetic nephropathy
Image: Diabetic nephropathy

Diabetic nephropathy means kidney damage that occurs as a result of diabetes. Researchers believe poor control of blood sugar or blood glucose levels is one of the reasons people with diabetes develop this type of kidney disease. Learn about diabetic nephropathy symptoms, diagnosis and treatment.

 

 

]]>

Diabetes and peritoneal dialysis
diabetes and pd 340x160Diabetes mellitus is the number one cause of kidney failure in the United States, leading many people to need dialysis. Learn about the relationship between diabetes and chronic kidney disease (CKD), as well as how people with diabetes can choose to do the home dialysis treatment, peritoneal dialysis (PD).

]]>

diabetes and pd

diabetes and pd 340x160

diabetes-definition-causes-and-symptoms

diabetes_definition_causes_and_symptoms



that specifies the number of meals you should eat each day and when to eat them. The principle behind such a plan is the diabetic food pyramid, that breaks down the type of foods you can eat and the portions sizes you should consume.

By eating a balanced diet at regular intervals you control the peaks and troughs of your blood sugar level. This is good for the long term diabetic complications because bad blood sugar control over an extended period can lead to a number of cardiovascular problems, not least, heart disease.

A good diet and exercise can also help you to lose weight. If this is an issue for you, it will make your worse and may lead to insulin replacement therapy. It is thought that excess weight make it harder for the natural insulin produced in the body to work effectively.

Blood circulation is also affected by and this can lead to eye problems over time. The typical complication is known as diabetic retinopathy. Diabetic retinopathy can lead to blood flowing into the aqueous humor and interfering with the sight to a detached retina. Part of ongoing treatment is a regular examination every six months. This should include an eye exam.

Diabetic neuropathy is another complication that is caused by poor circulation. This generally manifest in the extremities of the body - like the feet and hands. Because blood does not flow to these parts of the body as it should, they tend to be more susceptible to cuts and bruises. They also take more time to heal because the healing properties in the blood are not available. This often results in poor hands, and particularly feet. It is important to pay careful attention to the condition of the feet. Wash and dry them thoroughly each day and trim off any calluses, corns or long nails. Monitor any cuts and bruises and treat with medication if the cut is not healing. Wear diabetic socks and shoes if your feet are especially sensitive.

Diabetes complications can be serious but they can also be minimized by proper eating habits, regular exercise and careful monitoring of the body and any changes.

For more on eating the right foods for type 2 check out diabeticdietsplan.com/ . The site has features on the diabetic food pyramid and planning a diabetic diet. Adrian writes about treating naturally.




Here are some more diabetes articles...

Having A “sweet Tooth” Can Cause Wrinkles
By jm
Halloween is over and a lot of people, not just kids, had a great time indulging in candies, brownies, and all the sweets that abound during this trick or treat fest. But whether it's Halloween or Read more...
Are You In The High Risk Category Of Developing Heart Disease?
By Sky Fruit
To reduce your risk for heart disease or keep it low, it is very important to control any other risk factors you may have such as high blood pressure and smoking. If you are Read more...

Efficacy of Adding Sitagliptin or Pioglitazone to T2DM Insufficiently Controlled With Metformin and Sulfonylurea
<b>Condition</b>:   Type 2 Diabetes<br/><b>Interventions</b>:   Drug: Sitagliptin;   Drug: pioglitazone<br/><b>Sponsor</b>:   Mackay Memorial Hospital<br/><b>Recruiting</b> - verified September 2010
Benefit/Risk Evaluation of Insuman Implantable Versus Insuplant Using Medtronic MiniMed Implantable Pump System in Patients With Type 1 Diabetes
<b>Condition</b>:   Diabetes Mellitus, Type 1<br/><b>Interventions</b>:   Drug: HUMAN INSULIN (BIOSYNTHETIC);   Drug: Insuplant<br/><b>Sponsor</b>:   Sanofi-Aventis<br/><b>Not yet recruiting</b> - verified September 2010
Efficacy and Safety of Linagliptin (BI 1356) in Black/African Americans With Type 2 Diabetes With a MTT Sub-study
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Interventions</b>:   Drug: Placebo;   Drug: Linagliptin<br/><b>Sponsor</b>:   Boehringer Ingelheim Pharmaceuticals<br/><b>Not yet recruiting</b> - verified September 2010
Effect of Formoterol on the Counterregulatory Hormonal Response to Hypoglycemia
<b>Condition</b>:   Type 1 Diabetes<br/><b>Intervention</b>:   Drug: Formoterol<br/><b>Sponsors</b>:   Yale University;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)<br/><b>Recruiting</b> - verified September 2010
Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice
<b>Condition</b>:   Type 1 Diabetes<br/><b>Intervention</b>:   Device: Diabetes Interactive Diary (DID)<br/><b>Sponsors</b>:   Consorzio Mario Negri Sud;   Sanofi-Aventis;   LifeScan<br/><b>Recruiting</b> - verified September 2010
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 1 Diabetes Mellitus
<b>Condition</b>:   Diabetes Mellitus, Type 1<br/><b>Intervention</b>:   Drug: Insulin LISPRO<br/><b>Sponsor</b>:   Halozyme Therapeutics<br/><b>Recruiting</b> - verified September 2010
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes Mellitus
<b>Condition</b>:   Diabetes Mellitus, Type II<br/><b>Intervention</b>:   Drug: Insulin LISPRO<br/><b>Sponsor</b>:   Halozyme Therapeutics<br/><b>Recruiting</b> - verified September 2010
Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 Diabetes: An Extension Trial to NN1250-3579
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Interventions</b>:   Drug: NN1250;   Drug: insulin glargine<br/><b>Sponsor</b>:   Novo Nordisk<br/><b>Not yet recruiting</b> - verified August 2010
Comparison of NN1250 With Insulin Glargine Plus Insulin Aspart With or Without Metformin and With/Without Pioglitazone in Type 2 Diabetes: An Extension Trial to NN1250-3582
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Interventions</b>:   Drug: NN1250;   Drug: insulin glargine;   Drug: insulin aspart<br/><b>Sponsor</b>:   Novo Nordisk<br/><b>Not yet recruiting</b> - verified August 2010
BI 10773 Dose Finder Study in Japanese Patients With Type 2 Diabetes Mellitus
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Interventions</b>:   Drug: BI 10773;   Drug: BI 10773;   Drug: BI 10773;   Drug: BI 10773;   Drug: Placebo<br/><b>Sponsor</b>:   Boehringer Ingelheim Pharmaceuticals<br/><b>Not yet recruiting</b> - verified August 2010
Risk Factors for Low Lymphocyte Count in Patients With Type 2 Diabetes
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Intervention</b>:   <br/><b>Sponsors</b>:   Bristol-Myers Squibb;   AstraZeneca<br/><b>Active, not recruiting</b> - verified August 2010
A Study of OPC-262 in Patients With Type 2 Diabetes
<b>Condition</b>:   Diabetes, Type 2<br/><b>Intervention</b>:   Drug: OPC-262<br/><b>Sponsor</b>:   Otsuka Pharmaceutical Co., Ltd.<br/><b>Recruiting</b> - verified August 2010
Glycemic Holter Study (Continuous Glucose Monitoring) -
<b>Condition</b>:   Type 2 Diabetes Mellitus<br/><b>Interventions</b>:   Drug: Vildagliptin;   Drug: Sitagliptin<br/><b>Sponsor</b>:   Novartis<br/><b>Recruiting</b> - verified August 2010
Psychosocial Interventions in the Treatment of Youth With Type 1 Diabetes Mellitus
<b>Condition</b>:   Diabetes Mellitus<br/><b>Intervention</b>:   Behavioral: psychosocial intervention<br/><b>Sponsor</b>:   Assaf-Harofeh Medical Center<br/><b>Recruiting</b> - verified August 2010
Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin and 500 mg Metformin XR Tablet (Manufactured in Mt Vernon, IN) Relative to 5 mg Saxagliptin Tablet and 500 mg Metformin XR Tablet (Manufactured in Evansville, IN)
<b>Condition</b>:   Diabetes Mellitus<br/><b>Interventions</b>:   Drug: saxagliptin;   Drug: metformin XR;   Drug: saxagliptin + metformin XR (FDC tablet)<br/><b>Sponsor</b>:   Bristol-Myers Squibb<br/><b>Completed</b> - verified August 2010
Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin/1000 mg Metformin XR (Manufactured in Mt Vernon, IN) Relative to 5 mg of Onglyza and 2 × 500 mg Glucophage XR
<b>Condition</b>:   Diabetes Mellitus<br/><b>Interventions</b>:   Drug: saxagliptin;   Drug: Glucophage XR;   Drug: saxagliptin + metformin XR (FDC tablet)<br/><b>Sponsor</b>:   Bristol-Myers Squibb<br/><b>Completed</b> - verified August 2010
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-4)
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Interventions</b>:   Drug: Insulin Glargine;   Drug: LY2189266<br/><b>Sponsor</b>:   Eli Lilly and Company<br/><b>Not yet recruiting</b> - verified August 2010
Comparison of NN1250 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes: An Extension Trial to NN1250-3585
<b>Condition</b>:   Diabetes Mellitus, Type 1<br/><b>Interventions</b>:   Drug: NN1250;   Drug: insulin detemir (Levemir®);   Drug: insulin aspart<br/><b>Sponsor</b>:   Novo Nordisk<br/><b>Not yet recruiting</b> - verified August 2010
Exploratory Study to Evaluate the Efficacy of Androxal in Controlling Blood Glucose in Men With Type-2 Diabetes Mellitus and Secondary Hypogonadism or Adult-Onset Idiopathic Hypogonadotropic Hypogonadism
<b>Conditions</b>:   Type 2 Diabetes Mellitus;   Secondary Hypogonadism<br/><b>Interventions</b>:   Drug: Placebo;   Drug: enclomiphene citrate<br/><b>Sponsor</b>:   Repros Therapeutics Inc.<br/><b>Not yet recruiting</b> - verified August 2010
Subcutaneous Administration of Teplizumab in Adults With Type 1 Diabetes
<b>Condition</b>:   Type 1 Diabetes Mellitus<br/><b>Intervention</b>:   Drug: teplizumab or placebo<br/><b>Sponsors</b>:   MacroGenics;   Eli Lilly and Company<br/><b>Recruiting</b> - verified August 2010
Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Patients With Type 2 Diabetes Mellitus (0431-251)
<b>Condition</b>:   Type 2 Diabetes Mellitus<br/><b>Interventions</b>:   Drug: sitagliptin phosphate;   Drug: Glimepiride<br/><b>Sponsor</b>:   Merck<br/><b>Not yet recruiting</b> - verified August 2010
Four-Hour Evaluation of a Medical Food in Subjects With Type 2 Diabetes
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Interventions</b>:   Other: Experimental nutritional formula #M979;   Other: Standard food<br/><b>Sponsor</b>:   Abbott Nutrition<br/><b>Completed</b> - verified July 2010
Modulation of Free Fatty Acids in Heart Failure Patients With Diabetes: "Effect on Left Ventricular Function"
<b>Conditions</b>:   Heart Failure;   Diabetes<br/><b>Interventions</b>:   Other: Metabolic substrate modulation;   Other: metabolic substrate modulation<br/><b>Sponsors</b>:   University of Aarhus;   Danish Heart Foundation<br/><b>Recruiting</b> - verified August 2010
Study of Two Oral Formulations of LX4211 in Patients With Type 2 Diabetes Mellitus
<b>Condition</b>:   Type 2 Diabetes Mellitus<br/><b>Interventions</b>:   Drug: 300 mg LX4211 (150 mg tablets);   Drug: 300 mg LX4211 (50 mg tablets);   Drug: 300 mg LX4211 (liquid)<br/><b>Sponsor</b>:   Lexicon Pharmaceuticals<br/><b>Not yet recruiting</b> - verified August 2010
Hormones and Sexual Function Predict Outcomes in Revascularized Men With Diabetes
<b>Conditions</b>:   Androgen Deficiency (AD);   Erectile Dysfunction (ED);   Development of Predictive Cardiovascular/Cerebrovascular AE<br/><b>Intervention</b>:   <br/><b>Sponsors</b>:   Mount Sinai School of Medicine;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)<br/><b>Recruiting</b> - verified August 2010
A Multi-professional Team Intervention on Physical Activity Referrals in Primary Care Patients With Cardiovascular Risk Factors?the Dalby Lifestyle Intervention Cohort (DALICO) Study
<b>Condition</b>:   Motivation for Physical Activity<br/><b>Interventions</b>:   Behavioral: Multi-professional team intervention with PAR, lifestyle brochure;   Behavioral: Ordinary recommendations on health behaviours, lifestyle brochure<br/><b>Sponsors</b>:   Region Skane;   Swedish Council for Working Life and Social Research<br/><b>Not yet recruiting</b> - verified August 2010
Exercise Program Combined or Not With Nutritional intErvention in Adults With tyPe 2 Diabetes
<b>Conditions</b>:   Overweight;   Obesity;   Type 2 Diabetes<br/><b>Interventions</b>:   Behavioral: Caloric restriction;   Behavioral: Diet intervention and structured exercise training program<br/><b>Sponsor</b>:   Institut de Recherches Cliniques de Montreal<br/><b>Not yet recruiting</b> - verified August 2010
A 12-week, Multicentric Study to Evaluate the Safety and Efficacy of Bisoprolol in Diabetic and Hypertensive Filipinos
<b>Condition</b>:   Hypertension<br/><b>Intervention</b>:   Drug: Bisoprolole<br/><b>Sponsor</b>:   Merck KGaA<br/><b>Recruiting</b> - verified August 2010
Safety and Efficacy of Chlorthalidone + Amiloride to Elderly Patients Treatment With Arterial Hypertension
<b>Condition</b>:   Arterial Hypertension<br/><b>Interventions</b>:   Drug: Chlorthalidone 25 mg + amiloride hydrochloride 5 mg;   Drug: Higroton® Laboratório Novartis<br/><b>Sponsor</b>:   Eurofarma Laboratorios Ltda<br/><b>Not yet recruiting</b> - verified August 2010
n-3 Polyunsaturated Fatty Acids (PUFA) Supplementation in Young Women With Polycystic Ovary Syndrome (PCOS)
<b>Condition</b>:   Polycystic Ovary Syndrome<br/><b>Intervention</b>:   Dietary Supplement: LC n-3 PUFA (fish oil) Supplement<br/><b>Sponsors</b>:   The Adelaide and Meath Hospital;   University College Dublin<br/><b>Completed</b> - verified July 2008